Page 3 - Scientific Library
PARP and Top1 inhibitors most beneficial in endonuclease-deficient cancer cells
The synergistic combination of Poly(ADP-ribose) polymerases (PARP) and Topoisomerase I (Top1) inhibitors most beneficial on endonuclease-deficient cancer cells in cancer therapies ?
This is one